The three clusters were characterised by a different prevalence of musculoskeletal and renal activity, as well as use of immunosuppressants, with an apparent trend across clusters from the lowest prevalence in DORIS remission-enriched cluster 1, to intermediate prevalence in the mixed cluster 2, and the highest prevalence in cluster 3 that comprised the lowest proportion of DORIS remitters, as summarised in table 2 .
← all excerpts
Molecular characterisation of lupus low disease activity state (LLDAS) and DORIS remission by whole-blood transcriptome-based pathways in a pan-European systemic lupus erythematosus cohort.
1
—
—